News about Global Pharma

Lilly to Establish USD 5 Billion API Manufacturing Facility in Virginia

The new site in Virginia marks the first of four new US manufacturing sites that Lilly plans to announce this year.

Global Pharma | 17/09/2025 | By Dineshwori |  198

FDA Grants BTD to Raludotatug Deruxtecan for Platinum-Resistant Ovarian Cancer

This is the first BTD granted for Raludotatug Deruxtecan, the second for the Daiichi Sankyo-Merck partnership and the 15th across Daiichi Sankyo’s oncology portfolio, marking a significant milestone in the companies’ joint efforts to develop innovative cancer therapies.

Global Pharma | 16/09/2025 | By Dineshwori |  256

India's Pharma Exports Rise Nearly 7 percent in August 2025

India’s exports of drugs and pharmaceuticals climbed 6.94 percent from USD 2.35 billion in August 2024 to USD 2.51 billion in August 2025.

Global Pharma | 16/09/2025 | By Dineshwori |  586

Atavistik Bio Appoints Dr. Susan Pandya as Chief Medical Officer

As CMO, Dr. Susan Pandya will lead all clinical development strategy and execution for Atavistik Bio, including the ongoing Phase 1 clinical trial of its lead programme, ATV-1601.

Global Pharma | 15/09/2025 | By Dineshwori |  214

Mycenax, SPERA PHARMA Form Alliance to Streamline ADC Manufacturing

Mycenax Biotech has formed a strategic alliance with Japan’s SPERA PHARMA to provide an integrated end-to-end development and manufacturing platform for antibody-drug conjugates (ADCs) and bioconjugates.

Global Pharma | 15/09/2025 | By Mrinmoy Dey |  163

Mesoblast Launches FDA-Approved Ryoncil for Pediatric Graft Versus Host Disease

Mesoblast has announced the commercial launch of Ryoncil (remestemcel-L-rknd) in the United States for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients aged two months and older.

Global Pharma | 15/09/2025 | By Dineshwori |  237

Philips and Masimo Renew Partnership to Accelerate Development of Next-Gen Monitoring Solutions

As part of the expanded partnership, Masimo’s advanced monitoring technologies — including SET pulse oximetry, Radius PPG, and a range of sensor innovations — will be integrated into Philips’ multi-parameter patient monitoring platforms.

Global Pharma | 13/09/2025 | By Dineshwori |  135

MIRA Secures Shareholder Approval to Acquire SKNY

The acquisition strengthens MIRA’s pipeline with SKNY-1, a differentiated oral candidate that has demonstrated up to 30 percent weight loss and nicotine craving reversal in preclinical studies.

Global Pharma | 13/09/2025 | By Dineshwori |  137

UK Risks Losing Global Life Sciences Edge as Pharma Investment Decline, ABPI Warns

The UK risks losing its world-leading position in life sciences as investment in pharmaceutical research and development continues to fall behind international competitors, according to a new report from the Association of the British Pharmaceutical Industry (ABPI).

Global Pharma | 12/09/2025 | By Dineshwori |  324

Otsuka Acquires CAN10 from Cantargia

The deal transfers Cantargia’s CAN10 antibody programme to Otsuka, with Cantargia securing an upfront payment of USD 33 Million.

Global Pharma | 12/09/2025 | By Dineshwori |  255